Studies have shown that in rare cases of NSCLC, mutations that occur in the PIK3CA and PI3K/AKT/mTOR pathways can be inhibited by increasing PTEN protein expression.367. This evidence concerns the gene MTOR and non-small cell lung carcinoma.